Comorbid IHD in Patients with COPD: Definition, Risk Factors, Diagnostic Criteria
PDF

Keywords

chronic obstructive pulmonary disease
coronary heart disease
cardiorespiratory pathology

How to Cite

Gerych, P. R. (2014). Comorbid IHD in Patients with COPD: Definition, Risk Factors, Diagnostic Criteria. Galician Medical Journal, 21(4), 38-42. Retrieved from https://ifnmujournal.com/gmj/article/view/380

Abstract

The objective of the research was to identify risk factors for comorbid coronary artery disease in patients with acute exacerbation of COPD stage III, groups C and D in clinical practice and offer diagnostic methods and criteria to predict the course of IHD in this category of patients. Materials and methods. In accordance with the specific purpose and objectives of the research 210 patients with acute exacerbation of COPD stage III, groups C and D were examined. Results. In case of co-existent cardiorespiratory pathology caused by degeneration in COPD stage III, groups C, D and IHD, stable angina (SA) I-II FC, 50 (53.19%) patients with exacerbations of COPD stage III developed stable angina I-II FC or episodes of silent myocardial ischemia and 44 (46.81%) patients had evidence of a threat of clinical destabilization of IHD.

PDF

References

Avdeyev S.N. Chronic obstructive pulmonary disease as a systemic disease. Pulmonologiya. 2007; 2: 104-116.

Amosova K.M., Konopliova L.F., Sichinava D.Sh., Krychynska I.V. Ischemic heart disease in patients with chronic obstructive pulmonary disease: some clinical features and morphofunctional state of the myocardium according to a retrospective analysis. Ukr. pulmonol. zhurn. 2008; 1: 9-12.

Amosova K.M., Konopliova L.F., Sichinava D.Sh. Diagnosis and treatment of ischemic heart disease in patients with chronic obstructive pulmonary disease. Ukr. pulmonol. zhurn. 2009; 2: 8-11.

Vikentyev V.V. Myocardial ischemia and disturbance of left ventricular diastolic function. Rus. med. zhurn. 2000; 5: 18-25.

Voronkov L.G. Primary prevention of heart failure is a high and growing priority for modern cardiology. Ukr. kardiolog. zhurn. 2004; 4: 9-13.

Havrysiuk V.K. Systemic effects of COPD: clinical features, diagnosis and treatment. Ukr. pulmonol. zhurn. 2009; 2: 7.

Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Translated by Chuchalin A.G. M. Atmosfera. 2003.

Dinova O.P., Tkachuk V.K. Left ventricular remodeling and changes in functional reserve in patients with ischemic heart disease. Halytskyi likarskyi visnyk. 2008; 15(4): 15-18.

Global Initiative for Chronic Obstructive Lung Disease. Workshop report, global strategy for diagnosis, management, and prevention of COPD. Update 2013. Bethesda, National Institutes of Health, National Heart, Lung and Blood Institute. 2013.

Order of the Ministry of Health Care of Ukraine No 555 dated June 27, 2013 “On approval and implementation of medical-and-technical documents on standardization of medical care in chronic obstructive pulmonary disease”. Kyiv. 2013.

Order of the Ministry of Health Care of Ukraine No 436 dated July 03, 2006 “On approval and implementation of protocols for provision of medical services in cardiology”. 2007; 146.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.